These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 17487382)

  • 1. Overexpression of SPARC protein contrasts with its transcriptional silencing by aberrant hypermethylation of SPARC CpG-rich region in endometrial carcinoma.
    Rodríguez-Jiménez FJ; Caldés T; Iniesta P; Vidart JA; Garcia-Asenjo JL; Benito M
    Oncol Rep; 2007 Jun; 17(6):1301-7. PubMed ID: 17487382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions.
    Sato N; Fukushima N; Maehara N; Matsubayashi H; Koopmann J; Su GH; Hruban RH; Goggins M
    Oncogene; 2003 Aug; 22(32):5021-30. PubMed ID: 12902985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of secreted protein acidic and rich in cystein in esophageal carcinoma and its relation to carcinoma progression.
    Yamashita K; Upadhay S; Mimori K; Inoue H; Mori M
    Cancer; 2003 May; 97(10):2412-9. PubMed ID: 12733139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer.
    Sasaki M; Kaneuchi M; Sakuragi N; Dahiya R
    Cancer Res; 2003 Jun; 63(12):3101-6. PubMed ID: 12810635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant overexpression of SPARC/osteonectin mRNA in pancreatic cancer compared to cancer of the papilla of Vater.
    Prenzel KL; Warnecke-Eberz U; Xi H; Brabender J; Baldus SE; Bollschweiler E; Gutschow CA; Hölscher AH; Schneider PM
    Oncol Rep; 2006 May; 15(5):1397-401. PubMed ID: 16596217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent inactivation of RUNX3 in endometrial carcinoma.
    Yoshizaki T; Enomoto T; Fujita M; Ueda Y; Miyatake T; Fujiwara K; Miyake T; Kimura T; Yoshino K; Kimura T
    Gynecol Oncol; 2008 Sep; 110(3):439-44. PubMed ID: 18572225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of SPARC expression in reactive stroma associated with human epithelial ovarian cancer.
    Brown TJ; Shaw PA; Karp X; Huynh MH; Begley H; Ringuette MJ
    Gynecol Oncol; 1999 Oct; 75(1):25-33. PubMed ID: 10502421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The differential expression of SPARC in esophageal squamous cell carcinoma.
    Che Y; Luo A; Wang H; Qi J; Guo J; Liu Z
    Int J Mol Med; 2006 Jun; 17(6):1027-33. PubMed ID: 16685412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of estrogen receptor by the methylation of the estrogen receptor gene in endometrial carcinoma.
    Shiozawa T; Itoh K; Horiuchi A; Konishi I; Fujii S; Nikaido T
    Anticancer Res; 2002; 22(1A):139-43. PubMed ID: 12017277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gamma-Linolenic acid regulates the expression and secretion of SPARC in human cancer cells.
    Watkins G; Martin TA; Bryce R; Mansel RE; Jiang WG
    Prostaglandins Leukot Essent Fatty Acids; 2005 Apr; 72(4):273-8. PubMed ID: 15763439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphovascular invasion of colorectal cancer is correlated to SPARC expression in the tumor stromal microenvironment.
    Yoshimura T; Nagahara M; Kuo C; Turner RR; Soon-Shiong P; Hoon DS
    Epigenetics; 2011 Aug; 6(8):1001-11. PubMed ID: 21725199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased levels of SPARC (osteonectin) in human breast cancer tissues and its association with clinical outcomes.
    Watkins G; Douglas-Jones A; Bryce R; Mansel RE; Jiang WG
    Prostaglandins Leukot Essent Fatty Acids; 2005 Apr; 72(4):267-72. PubMed ID: 15763438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.
    Taniguchi H; Yamamoto H; Akutsu N; Nosho K; Adachi Y; Imai K; Shinomura Y
    J Pathol; 2007 Oct; 213(2):131-9. PubMed ID: 17724792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypermethylation in promoter region of E-cadherin gene is associated with tumor dedifferention and myometrial invasion in endometrial carcinoma.
    Saito T; Nishimura M; Yamasaki H; Kudo R
    Cancer; 2003 Feb; 97(4):1002-9. PubMed ID: 12569599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma.
    Lau CP; Poon RT; Cheung ST; Yu WC; Fan ST
    J Pathol; 2006 Dec; 210(4):459-68. PubMed ID: 17029219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant expression of SPARC and its impact on proliferation and apoptosis in ADPKD cyst-lining epithelia.
    Wang W; Mei C; Tang B; Zhao H; Xu C; Li Z; Shen X; Fu W; Dai B
    Nephrol Dial Transplant; 2006 May; 21(5):1278-88. PubMed ID: 16421164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OPCML gene promoter methylation and gene expression in tumor and stroma cells of invasive cervical carcinoma.
    Ye F; Zhang SF; Xie X; Lu WG
    Cancer Invest; 2008 Jul; 26(6):569-74. PubMed ID: 18584347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Methylation and expression of the p16 gene in endometrial carcinoma].
    Chao H; Sun J; Lu S
    Zhonghua Zhong Liu Za Zhi; 2000 May; 22(3):228-31. PubMed ID: 11778238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypermethylation in the p16 promoter region in the carcinogenesis of endometrial cancer in Japanese patients.
    Yanokura M; Banno K; Susumu N; Kawaguchi M; Kuwabara Y; Tsukazaki K; Aoki D
    Anticancer Res; 2006; 26(2A):851-6. PubMed ID: 16619479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.